The North America software as a medical device market is expected to reach US$ 39,854.20 million by 2027 from US$ 8,353.94 million in 2019. The market is anticipated to grow at a CAGR of 22.2% from 2020 to 2027. The growth of the market is attributed to the increasing adoption of IoT in healthcare and advantages of software as medical device (SaMD) .On the other hand, the threat of data breach hinders the growth of market.
The growth of the market is highly dependent on technological advancements. The North American technology players have been increasingly partnering with pharmaceuticals companies. For instance, BrightInsight entered into a Global Digital Health Partnership with AstraZeneca to build and manage its digital health solutions within a regulatory-compliant environment. Similarly, CompliancePath and Ideagen have entered into a Product Validation partnership to extend their ongoing validation accelerator program to include all life science-related software products.
The North America Software as medical device market, based on the device type, is segmented into smartphones/tablets, wearable devices, and PC/laptops. In 2019, smartphones/tablets segment held the largest share of the market. However, wearable devices segment is expected register the highest CAGR during the forecast period. The North America Software as medical device market, based on application, is segmented into screening and diagnosis, monitoring and alerting, and disease management. In 2019, screening and diagnosis segment held the largest share of the market. However, the monitoring and alerting segment is expected to grow at the fastest rate during the forecast period. The North America Software as medical device market, based on the deployment type, is segmented into cloud and on-premises. In 2019, the cloud segment held the largest share of the market, and it is also expected to register the highest CAGR during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the Software as Medical device include the World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Pan American Health Organization.
Reasons to Buy
The growth of the market is highly dependent on technological advancements. The North American technology players have been increasingly partnering with pharmaceuticals companies. For instance, BrightInsight entered into a Global Digital Health Partnership with AstraZeneca to build and manage its digital health solutions within a regulatory-compliant environment. Similarly, CompliancePath and Ideagen have entered into a Product Validation partnership to extend their ongoing validation accelerator program to include all life science-related software products.
The North America Software as medical device market, based on the device type, is segmented into smartphones/tablets, wearable devices, and PC/laptops. In 2019, smartphones/tablets segment held the largest share of the market. However, wearable devices segment is expected register the highest CAGR during the forecast period. The North America Software as medical device market, based on application, is segmented into screening and diagnosis, monitoring and alerting, and disease management. In 2019, screening and diagnosis segment held the largest share of the market. However, the monitoring and alerting segment is expected to grow at the fastest rate during the forecast period. The North America Software as medical device market, based on the deployment type, is segmented into cloud and on-premises. In 2019, the cloud segment held the largest share of the market, and it is also expected to register the highest CAGR during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the Software as Medical device include the World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Pan American Health Organization.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe software as medical device market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe software as medical device market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Software as Medical Devices - Market Landscape
5. North America Software as Medical Device Market - Industry Dynamics
6. Software as Medical Devices Market - Regional Analysis
7. Software as Medical Devices Market Analysis - By Device Type
8. Software as Medical Device Market Analysis - By Application
9. Software as Medical Device Market Analysis - By Deployment Type
10. Software as Medical Device Market - Geographic Analysis
11. Impact Of COVID-19 Pandemic on North America Software As Medical Device Market
12. Software as Medical Devices Market - Industry Landscape
13. Company Profiles
14. Appendix
Companies Mentioned
- Velentium LLC
- Tietronix Software, Inc.
- S3 Connected Health
- Zühlke Group
- Science Group
- Inzentiz
- Cambridge Consultants Inc
- BrightInsight, Inc.
- CompliancePath
- Jabil Inc.
- Phillips-Medisize
- Pro4People Sp. Z.o.o
